Reval Announces Position on Proposed Regulation of OTC Derivatives Market

New York, June 19, 2009 – Reval, a global derivative risk management and hedge accounting solutions provider to over 250 of the world’s largest and most complex corporations, announced today its position on the Obama administration’s plans to regulate the over-the-counter (OTC) derivatives market.

In a letter to Treasury Secretary Timothy F. Geithner, Reval CEO and Co-Founder Jiro Okochi stated that Reval “understands and agrees with the need to better regulate the over-the-counter (OTC) derivatives market, and that better transparency, controls and the ability to clear OTC derivatives would help prevent future systemic risk. However, the broad regulatory reform suggested for all OTC derivatives—despite their intended use—may in fact increase risk into the system.”

According to Okochi, “A decrease in the use of OTC derivatives by companies who are true hedgers of business risk—those not likely to be a cause of systemic risk, past or future—may occur because the cost of margining and reporting would be too high. Consequently, any proprietary hedging strategies that would provide a competitive business advantage would be lost.”

Corporations, financial institutions, and accounting firms rely on Reval for independent valuations of derivative transactions and to assist with the hedge accounting of foreign exchange, interest rates, energy, credit, commodities, and other asset classes.

For further information about Reval, please see www.reval.com. Biographical information on Jiro Okochi can be found at http://www.reval.com/news/Pages/journalists.aspx

About Reval

Reval is a global SaaS provider for Treasury and Risk Management, helping enterprises better manage cash, liquidity and financial risk, and account for and report on complex financial instruments and hedging activities.

For more information, visit www.reval.com or email info@reval.com.

Note to editors: Trademarks and registered trademarks remain the property of their respective owners.